# Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC

> **NCT05636397** · NA · RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 36 (estimated)

## Conditions studied

- BPD - Bronchopulmonary Dysplasia
- Pulmonary Hypertension
- NEC

## Interventions

- **DIETARY_SUPPLEMENT:** L-Citrulline

## Key facts

- **NCT ID:** NCT05636397
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-03
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636397, "Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05636397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*